浙江临床医学
浙江臨床醫學
절강림상의학
ZHEJIANG CLINICAL MEDICAL JOURNAL
2013年
4期
444-446
,共3页
黄洪华%李拥军*%张卫华%于洪波%王威
黃洪華%李擁軍*%張衛華%于洪波%王威
황홍화%리옹군*%장위화%우홍파%왕위
肝动脉门静脉瘘%原发性肝癌%栓塞%明胶海绵
肝動脈門靜脈瘺%原髮性肝癌%栓塞%明膠海綿
간동맥문정맥루%원발성간암%전새%명효해면
Hepatic arteryportal shunting%Hepatocellular carcinoma%Embolization therapeutic%Gelfoam
目的观察明胶海绵对原发性肝癌合并动静脉瘘栓塞治疗的疗效.方法对28例原发性肝癌合并动静脉瘘患者,行超选择插管造影明确瘘口类型、分流量及肿瘤血供后,对瘘口进行堵塞,并行肿瘤化疗栓塞治疗(TACE).闭塞瘘口材料主要用明胶海绵.结果28例中23例一次性瘘口堵塞成功(其中21例同时行肿瘤血供动脉栓塞),5例因瘘口大未能完全封堵.在后续介入治疗中发现,原瘘口封堵成功23例中13例瘘口重新开通或有新的瘘口出现,其中8例作再次封堵均成功.结论超选择插管用明胶海绵对原发性肝癌动静脉瘘的栓塞治疗是一种安全、有效、并发症少的方法,能为肝癌的进一步治疗创造机会.
目的觀察明膠海綿對原髮性肝癌閤併動靜脈瘺栓塞治療的療效.方法對28例原髮性肝癌閤併動靜脈瘺患者,行超選擇插管造影明確瘺口類型、分流量及腫瘤血供後,對瘺口進行堵塞,併行腫瘤化療栓塞治療(TACE).閉塞瘺口材料主要用明膠海綿.結果28例中23例一次性瘺口堵塞成功(其中21例同時行腫瘤血供動脈栓塞),5例因瘺口大未能完全封堵.在後續介入治療中髮現,原瘺口封堵成功23例中13例瘺口重新開通或有新的瘺口齣現,其中8例作再次封堵均成功.結論超選擇插管用明膠海綿對原髮性肝癌動靜脈瘺的栓塞治療是一種安全、有效、併髮癥少的方法,能為肝癌的進一步治療創造機會.
목적관찰명효해면대원발성간암합병동정맥루전새치료적료효.방법대28례원발성간암합병동정맥루환자,행초선택삽관조영명학루구류형、분류량급종류혈공후,대루구진행도새,병행종류화료전새치료(TACE).폐새루구재료주요용명효해면.결과28례중23례일차성루구도새성공(기중21례동시행종류혈공동맥전새),5례인루구대미능완전봉도.재후속개입치료중발현,원루구봉도성공23례중13례루구중신개통혹유신적루구출현,기중8례작재차봉도균성공.결론초선택삽관용명효해면대원발성간암동정맥루적전새치료시일충안전、유효、병발증소적방법,능위간암적진일보치료창조궤회.
Objective To explore the strategy of gelfoam in primary hepatocellular carcinoma(HCC)with hepatic arteryportal shunting(APS)interventional embolization treatment method and the curative effect. Methods 28 cases who were HCC combined with APS were collected in the study. The details of shunting and tumor feeding vessel were evaluated by superselective angiography and both blocking up fistula and chemoembolization treatment were carried out. The shunting were blocked with different specifications of the gelfoam. Results 23 shunts were completely closed successfully. 5 shunts were partly closed .21 cases had successful tumor embolization. In 13 patients,the shunts reopened or new shunt emerged in later therapy, and 8 of them were closed after second embolization. Conclusion Superselective embolization with gelfoam at the shunt is safe,effective and full of little complications to the therapy of hepatic arteryportal shunts resulted from primary liver cancer.It can create opportunities for further treatment for hepatocellular carcinoma.